Alcon

ALC Healthcare Medical Instruments & Supplies

Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS fell 100.0%, free cash flow was flat and total debt was flat, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.

66.18 0.40 −0.60%
Market cap
$32.1B
P/E
50.5×
Fwd P/E
31.0×
Dividend yield
0.53%
F-score
6/9
Altman Z
n/a
Beneish M
−2.56
Dividend safety
66/100
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

5 6 6 7
ROE
4.82% 4.50% 3.71% 2.94%
ROA
3.38% 3.17% 2.62% 2.06%
ROIC
3.56% 3.38% 2.94% 2.38%
Return on Tangible Assets
13.02% 11.99% 9.78% 7.84%
Average Days of Receivables
69.49 68.85 68.99 70.57
Free Cash Flow per Share
2.81 3.27 3.28 3.28
Free Cash Flow
1,385.00 1,613.00 1,596.00 1,594.00
Other line items

Show all line items

Columns are period end dates